Abstract
In therapeutics research, the nitro compounds are part of an important group of drugs with multiple pharmacological activities. However, in drug design, the inclusion of a nitro group in a molecule changes the physico-chemical and electronic properties and is associated with increased mutagenicity and carcinogenicity. In addition, several studies have related the relationship between the antimicrobial and/or anti-protozoal activity and the mutagenic effect to reduction of the nitro group. This work reviews the toxicity of nitro compounds and shows how the use of prodrugs can increase the biological activity and decrease the genotoxicity of nitro compounds, without any modification in nitro reduction behavior, but rather by physico-chemical improvement. Examples are given of metronidazole and nitrofurazone prodrugs.
Keywords: Prodrugs, nitro-compounds, metronidazol, nitrofurazone, genotoxicity, physico-chemical properties, nitroheterocyclic compounds, half-life, nitroimidazoles, Chagas disease
Current Pharmaceutical Design
Title: A Prodrug Approach to Improve the Physico-Chemical Properties and Decrease the Genotoxicity of Nitro Compounds
Volume: 17 Issue: 32
Author(s): Man Chin Chung, Priscila Longhin Bosquesi and Jean Leandro dos Santos
Affiliation:
Keywords: Prodrugs, nitro-compounds, metronidazol, nitrofurazone, genotoxicity, physico-chemical properties, nitroheterocyclic compounds, half-life, nitroimidazoles, Chagas disease
Abstract: In therapeutics research, the nitro compounds are part of an important group of drugs with multiple pharmacological activities. However, in drug design, the inclusion of a nitro group in a molecule changes the physico-chemical and electronic properties and is associated with increased mutagenicity and carcinogenicity. In addition, several studies have related the relationship between the antimicrobial and/or anti-protozoal activity and the mutagenic effect to reduction of the nitro group. This work reviews the toxicity of nitro compounds and shows how the use of prodrugs can increase the biological activity and decrease the genotoxicity of nitro compounds, without any modification in nitro reduction behavior, but rather by physico-chemical improvement. Examples are given of metronidazole and nitrofurazone prodrugs.
Export Options
About this article
Cite this article as:
Chin Chung Man, Longhin Bosquesi Priscila and Leandro dos Santos Jean, A Prodrug Approach to Improve the Physico-Chemical Properties and Decrease the Genotoxicity of Nitro Compounds, Current Pharmaceutical Design 2011; 17 (32) . https://dx.doi.org/10.2174/138161211798194512
DOI https://dx.doi.org/10.2174/138161211798194512 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Determination of Ethinylestradiol and Levo-Norgestrel Using Microemulsion Electrokinetic Chromatography
Current Analytical Chemistry Patenting of Nanopharmaceuticals in Drug Delivery: No Small Issue
Recent Patents on Drug Delivery & Formulation 5-Fluorouracil Buccal Tablets for Locoregional Chemotherapy of Oral Squamous Cell Carcinoma: Formulation, Drug Release and Histological Effects on Reconstituted Human Oral Epithelium and Porcine Buccal Mucosa
Current Drug Delivery Cyclodextrin Based Nanosponges: A Multidimensional Drug Delivery System and its Biomedical Applications
Current Drug Delivery Challenges and Opportunities of Nanotechnological based Approach for the Treatment of Tuberculosis
Current Pharmaceutical Design Recent Advances in the Discovery of Novel Anti-Herpetic Agents from Chinese Herbal Medicines
Current Organic Chemistry Perioperative Management of Obese Parturients
Current Women`s Health Reviews Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response
Current Cancer Drug Targets Overview on Inhalable Nanocarriers for Respiratory Immunization
Current Pharmaceutical Design Magnetic Resonance Imaging of the Cervix, and its Relevance to the Revised International Federation of Gynecology and Obstetrics (FIGO) Staging
Current Medical Imaging An Overview of Pathogenesis and Pathophysiology in Endometriosis
Current Women`s Health Reviews Adenoviral Gene Delivery for HIV-1 Vaccination
Current Gene Therapy Sodium Lauryl Sulfate, a Microbicide Effective Against Enveloped and Nonenveloped Viruses
Current Drug Targets Women’s Ginseng (Angelica sinensis): An Ethnopharmacological Dossier
Current Traditional Medicine Computed Tomographic Evaluation of Colonic Diverticulum Complications
Current Medical Imaging Chitosan and Its Use in Design of Insulin Delivery System
Recent Patents on Drug Delivery & Formulation Complextation of Oppositely Charged Polymer: Novel Approaches for Drug Delivery
Current Drug Delivery Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates
Central Nervous System Agents in Medicinal Chemistry The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review
Current Drug Therapy